Description

8-Acetyl-3A,4,5,9B-Tetrahydro-3 H-Cyclopenta[ C ]Quinoline-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused-ring structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in developing new therapeutic agents, particularly within central nervous system (CNS) and anti-inflammatory drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of complex drug molecules and novel APIs.
• Medicinal Chemistry Research: Used extensively in R&D for structure-activity relationship (SAR) studies and lead optimization in drug discovery projects.
• Heterocyclic Compound Synthesis: A valuable scaffold for constructing more complex polycyclic frameworks common in modern pharmaceuticals.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis and scale-up projects.
• Reference Standard: Utilized as an analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Product Name	8-Acetyl-3A,4,5,9B-Tetrahydro-3 H-Cyclopenta[ C ]Quinoline-4-Carboxylic Acid
CAS No.	312714-12-8
Molecular Formula	C15H15NO3
Molecular Weight	257.29 g/mol
Synonyms	8-Acetyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxylic acid; 3H-Cyclopenta[c]quinoline-4-carboxylic acid, 8-acetyl-3a,4,5,9b-tetrahydro-; 8-Acetyl-3a,4,5,9b-tetrahydrocyclopenta[c]quinoline-4-carboxylic acid; 312714-12-8; 8-Acetyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxylic acid; Cyclopenta[c]quinoline-4-carboxylic acid derivative
EINECS	Contact for details

Quality Control

Our 8-Acetyl-3A,4,5,9B-Tetrahydro-3 H-Cyclopenta[ C ]Quinoline-4-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all specified parameters. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical research and production needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.